DRUG-INDUCED NEPHROTOXICITY: STRATEGIES FOR CLINICAL PRACTICE

Authors

  • Carolina Vitoratto Grunewald Autor
  • Camila Gomes da Silva Autor
  • Thiago de Almeida Garcia Autor
  • Leonardo Ichiro Hiratsuka Takemoto Autor
  • David Stênio da Silva Vieira Autor
  • Henrique Caetano Baptista Autor
  • Jessyca de Oliveira Silva Autor
  • Elvis Mathon Goes Santos de Jesus Autor

DOI:

https://doi.org/10.63330/aurumpub.014-001

Keywords:

Nephrotoxicity, Acute kidney injury, Nephrotoxic drugs, Prevention, Clinical medicine

Abstract

Drug-induced nephrotoxicity is a significant clinical complication associated with increased morbidity, mortality, and costs. This article presents essential strategies to mitigate the risk of drug-induced kidney injury. Identifying and monitoring high-risk patients is crucial, including those with pre-existing renal dysfunction, the elderly, patients with volume depletion, and those on nephrotoxic polypharmacy. Serial assessment of renal function is imperative. Dosage adjustment based on renal function and selection of less nephrotoxic therapeutic alternatives are key strategies. Adequate hydration, especially with amphotericin B, attenuates the tubular concentration of the drug. Avoiding concomitant administration of multiple nephrotoxic drugs is essential, requiring careful review of pharmacotherapy. Future research focuses on biomarkers for early detection and the development of less nephrotoxic drugs. Careful implementation of these strategies is critical to patient safety. It is evident that drug-induced nephrotoxicity requires a multifaceted approach, with prevention, early detection, and appropriate management to ensure patient safety and well-being.

Downloads

Download data is not yet available.

References

Johnson RJ et al. Comprehensive Clinical Nephrology, 5th ed. Elsevier: 2015.

Lucio RM et at. Tratado de Nefrologia, 19 ed. Rio de Janeiro: Atheneu, 2018.

Daugirdas, JT et al. Manual de Diálise, 59 ed. Rio de Janeiro: Guanabara Koogan, 2016.

Zatz, Roberto. Bases fisiológicas da nefrologia. São Paulo, Rio de Janeiro, Belo Horizonte,2012.

Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney inter., Suppl. 2012; 2: 1–138.

Brenner BM, editor. Brenner C Rector’s The Kidney. 10th ed. Philadelphia: Elsevier, 2016.

Pazhayattil GS, Shirali AC. Drug-induced impairment of renal function. Int J Nephrol Renovasc Dis. 2014;7:457-68.

Awdishu L, Mehta RL. The 6R’s of drug induced nephrotoxicity. BMC Nephrol. 2017;18(1):124.

Mehran R, Dangas GD, Weisbord SD. Contrast-Associated Acute Kidney Injury. N Engl J Med. 2019;380(22):2146-55.

Griffin BR, Liu KD, Teixeira JP. Critical Care Nephrology: Core Curriculum 2020. Am J Kidney Dis. 2020;75(3):435-52.

Simonetto DA, Gines P, Kamath OS. Hepatorenal syndrome: pathophysiology, diagnosis, and management. BMJ. 2020;370:m2687.

Moore PK, Hsu RK, Liu KD. Management of Acute Kidney Injury: Core Curriculum 2018. Am J Kidney Dis. 2018;72(1):136-48.

Jaber S, Paugam C, Futier E, Lefrant J-Y, Lasocki S, Lescot T, et al. Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial. The Lancet. 2018;392(10141):31-40.

Published

2025-08-21

How to Cite

DRUG-INDUCED NEPHROTOXICITY: STRATEGIES FOR CLINICAL PRACTICE. (2025). Aurum Editora, 1-11. https://doi.org/10.63330/aurumpub.014-001